• <em>De-Novo</em> B-Cell Prolymphocytic Leukemia
• A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia
• A particular presentation of a T cell large granular lymphocytic leukaemia
• A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies
• Acute visual change as first symptom of B-cell prolymphocytic leukaemia
• Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
• AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function
• Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan
• Anterior Chamber Cytology Confirms the Diagnosis of T-cell Prolymphocytic Leukemia Masquerading as Viral Retinal Necrosis
• Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
• B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas
• B-cell prolymphocytic leukemia after COVID-19 infection
• B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases
• B-cell prolymphocytic leukemia: an enduring bona fide entity
• B-prolymphocytic leukemia (B-PLL) with genetic aberrations involving <em>MYC</em> and <em>TP53</em>
• B-prolymphocytic leukemia (B-PLL) with genetic aberrations involving MYC and TP53
• Bendamustine and tofacitinib treatment of T-cell prolymphocytic leukemia: a case report
• Case report: CD8 positive T-cell Prolymphocytic Leukemia presenting complex karyotype with a rare chromosomal abnormality der(2)t(1;2)(q21;q37) and additional signals of the genes MYC, IGH, and TP53
• Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database
• Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
• CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11
• Circulating Monocytes Phagocytosing Lymphocytes in Small-cell Variant of T-cell Prolymphocytic Leukemia
• Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia
• Classification of indolent B-cell lymphomas : Novelties and open questions
• Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly
• Clinical Characteristics of Aggressive NK-Cell Leukemia
• Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma
• Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia
• Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India
• Cutaneous <em>Pneumocystis Jirovecii</em> Infection in an Allogeneic Stem Cell Transplant Recipient
• Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
• De-Novo B-Cell Prolymphocytic Leukemia
• Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
• Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia
• Disseminated Cryptococcosis With Prostate Involvement in a Patient With T-cell Prolymphocytic Leukemia and Prostate Cancer
• Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia
• Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase?
• Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation
• EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia
• Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
• Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia
• Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms
• From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature
• Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
• Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfalls
• Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation
• KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes
• Leukemia Cutis
• Leukemia Cutis
• Leveraging machine learning for predicting acute graft-versus-host disease grades in allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukaemia
• Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
• Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature
• Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network
• Lymphoproliferative Disorders
• Lymphoproliferative Disorders
• Mature T-Cell leukemias: Challenges in Diagnosis
• Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia
• Mycobacterial Spindle Cell Pseudotumor of the Nasal Cavity
• Non-Hodgkin lymphoma mimicking acute leukemia: a report of six cases and review of the literature
• Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
• Obituary for a diagnosis: B-cell prolymphocytic leukaemia (1974-2022)
• Optimizing Drug Combinations for T-PLL: Restoring DNA Damage and P53-Mediated Apoptotic Responses
• Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia
• Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report
• Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop
• Prolymphocytic Leukaemia: an Update on Biology and Treatment
• Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion
• Relapsed B-cell prolymphocytic leukemia (B-PLL) with distinctive granular inclusion bodies
• Retrospective analysis of a cohort of 41 <em>de novo</em> B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
• Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
• RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies
• Small cell variant anaplastic large cell lymphoma presenting as leukemia: A case report and review of Literature
• Successful treatment of acyclovir-resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T-cell prolymphocytic leukemia
• Successful Treatment of Disseminated Nocardiosis by Rapid Identification of the Organism via Genetic Analysis in a Leukemia Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
• Sunsetting B-prolymphocytic leukemia
• T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab)
• T-Cell Prolymphocytic Leukemia
• T-Cell Prolymphocytic Leukemia
• T-cell prolymphocytic leukemia with follicular mucinosis
• T-cell prolymphocytic leukemia with lung involvement presenting as crazy paving on high-resolution computed tomography
• T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases
• T-cell prolymphocytic leukemia, cerebriform variant
• T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
• T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments
• T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation
• T-PLL Presenting with an Indolent Course
• T-prolymphocytic leukaemia with sezary-like morphology
• T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis
• Targeting iron import to treat ANKL
• TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count
• The critical role of phytohemagglutinin-stimulated cell cultures in the diagnosis of T-cell prolymphocytic leukemia: A case-based approach
• The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research
• The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis
• The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL
• Therapeutic leukocytapheresis for leukostasis in chronic lymphocytic leukemia: A case report and literature review
• Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment
• Urticarial mycosis fungoides: A distinctive presentation with blood involvement and a peculiar immunophenotype
• Venetoclax induces deep and durable minimal residual disease-negative remission in high-risk TP53 disrupted B prolymphocytic leukaemia
• Zanubrutinib (Brukinsa): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with chronic lymphocytic leukemia
• Zanubrutinib (Brukinsa): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with chronic lymphocytic leukemia [Internet]